SPHS
Sophiris Bio, Inc.
SPHS
SPHS
Delisted
SPHS was delisted on the 11th of March, 2020.
25 hedge funds and large institutions have $3.61M invested in Sophiris Bio, Inc. in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
25
Holding in Top 10
–
Calls
$131K
Puts
$135K
Top Buyers
| 1 | +$95.8K | |
| 2 | +$79K | |
| 3 | +$74K | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$23K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$6.92K |
Top Sellers
| 1 | -$183K | |
| 2 | -$120K | |
| 3 | -$84K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$51.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$49K |